ClinicalTrials.Veeva

Menu

Cognitive Behavioural Therapy of Early Dementia (KORDIAL)

T

Technical University of Munich

Status

Completed

Conditions

Dementia

Treatments

Behavioral: Cognitive behavioral therapy for early Alzheimer's disease
Other: Control

Study type

Observational

Funder types

Other

Identifiers

NCT00735046
KOR-683-KUR-0000-I

Details and patient eligibility

About

A randomized, controlled, parallel-group trial to evaluate the efficacy of a cognitive behavioral therapy for patients with early dementia.

Full description

The KORDIAL study is a randomized, controlled, parallel-group trial evaluating the efficacy of a cognitive behavioral therapy for patients at the early stage of Alzheimer's disease. The 3-month experimental intervention consists of 12 individual sessions with regular involvement of carers or other patient proxies. Strategies for improving the patient's coping ability and for enhancing their psychological well-being are combined. The primary outcome criterion is functioning in the everyday context after completion of the intervention and after another 6 months. The control condition will be treatment as usual. The study will be conducted in 5 university outpatient units and in 5 specialist offices.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mild dementia (MMSE > 21) in Alzheimer's disease (ICD-10), proxy available

Exclusion criteria

  • Acute of unstable psychiatric or physical disease, proxy unavailable
  • Participation in another trial

Trial design

200 participants in 2 patient groups

1
Description:
Intervention
Treatment:
Behavioral: Cognitive behavioral therapy for early Alzheimer's disease
2
Description:
control
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems